Trial Profile
A phase I study of latanoprost/TEV 90100/timolol for treatment of glaucoma
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 04 Dec 2014
Price :
$35
*
At a glance
- Drugs Latanoprost/TEV 90100/timolol (Primary)
- Indications Glaucoma
- Focus Adverse reactions
- 04 Dec 2014 New trial record